Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.

ClinicalTrials.gov ID: NCT01352845

Public ClinicalTrials.gov record NCT01352845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 30, 2026, 4:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Placebo-controlled, Observer-blinded, Trial To Assess The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine When Administered As A 3-dose Regimen In Healthy Young Adults Aged >=18 To <26 Years

Study identification

NCT ID
NCT01352845
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
3,301 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Other
  • rLP2086 Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years to 25 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
Jan 31, 2015
Completion
Jan 31, 2015
Last update posted
Feb 22, 2016

2013 – 2015

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
31
Facility City State ZIP Site status
Coastal Clinical Research, Inc. Mobile Alabama 36608
Clinical Research Advantage, Inc./Desert Clinical Research, LLC Mesa Arizona 85213
Clinical Research Advantage, Inc./ Fiel Family and Sports Medicine, PC Tempe Arizona 85282
Clinical Research Advantage, Inc./ Fiel Family and Sports Medicine, PC Tempe Arizona 85283
Anaheim Clinical Trials LLC Anaheim California 92801
eStudySite La Mesa California 91942
Benchmark Research Sacramento California 95822
Broward Research Group Hollyood Florida 33024
Altus Research Inc. Lake Worth Florida 33461
Miami Research Associates South Miami Florida 33143
Palm Beach Research Center West Palm Beach Florida 33409
Johnson County Clin-Trials, Inc. Lenexa Kansas 66219
Benchmark Research Metairie Louisiana 70006
Milford Emergency Associates, Inc. Milford Massachusetts 01757
The Center for Pharmaceutical Research Kansas City Missouri 64114
Bellevue Urgent Care Bellevue Nebraska 68005
Meridian Clinical Research Bellevue Nebraska 68005
Pioneer Clinical Research, LLC Bellevue Nebraska 68005
Meridian Clinical Research, Omaha Nebraska 68134
Central New York Clinical Research Manlius New York 13104
PMG Research of Raleigh, LLC Raleigh North Carolina 27609
Community Research Cincinnati Ohio 45227
Rapid Medical Research, Inc. Cleveland Ohio 44122
Rapid Medical Research Cleveland Ohio 44122
PEAK Research, LLC Upper Saint Clair Pennsylvania 15241
Coastal Medical East Greenwich Rhode Island 02818
Omega Medical Research Warwick Rhode Island 02886
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Meridian Clinical Research Dakota Dunes South Dakota 57049
Clinical Research Associates, Inc. Nashville Tennessee 37203
Research Across America Dallas Texas 75234
Texas Center for Drug Development, Inc. Houston Texas 77081
Research Across America Katy Texas 77450
Advanced Clinical Research West Jordan Utah 84088
Premier Clinical Research Spokane Washington 99204-4880

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01352845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2016 · Synced Apr 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01352845 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →